DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction

Journal of Molecular Recognition

Volumn 10, Issue 6, 1997, Pages 245-255

  Bell, Achim ^a   Kittler, Leonhard ^a   Löber, Günter ^a   Zimmer, Christoph ^b  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Footprinting; Microscopic binding constants; Minor groove binders; RY repeat; Topoisomerase II cleavage

Indexed keywords

AMMONIUM DERIVATIVE; BISNETROPSIN; CHROMOMYCIN; CONGOCIDINE; DEOXYRIBONUCLEASE; DISTAMYCIN A; DNA BINDING; DNA FOOTPRINTING; DNA TOPOISOMERASE (ATP HYDROLYSING); ENZYME ACTIVITY; LIGAND; MICROSCOPY;

ANIMALS; BASE SEQUENCE; BINDING SITES; CATTLE; CHROMOMYCINS; DEOXYRIBONUCLEASE I; DISTAMYCINS; DNA; DNA FOOTPRINTING; DNA TOPOISOMERASES, TYPE II; DOSE-RESPONSE RELATIONSHIP, DRUG; GLOBINS; HUMANS; MOLECULAR SEQUENCE DATA; NETROPSIN; QUATERNARY AMMONIUM COMPOUNDS; THYMUS GLAND;

EID: 0031277411     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1352(199711/12)10:6<245::AID-JMR367>3.0.CO;2-3     Document Type: Article

References (59)

1. Abu-Daja, A., Brown, P. M. and Fox, K. R. (1995). DNA sequence preferences of several AT-selective minor groove binding ligands. Nucl. Acids Res. 23, 3385-3392.
2. Alsner, J., Sørensen, H. V., Schmidt, V. K., Sørensen, B. S. and Westergaard, O. (1996). Topoisomerase II-mediated DNA cleavage: evidence for distinct regions of enzyme-DNA contacts. J. Mol. Biol. 259, 317-324.
3. Andersen, A. H., Sørensen, B. S., Christiansen, K., Svejstrup, J. Q., Lund, K. and Westergaard, O. (1991). Studies of the topoisomerase II cleavage and religation reactions by use of a suicidal double-stranded DNA substrate. J. Biol. Chem. 226, 9203-9210.
4. 3 with small DNA duplexes: binding to GC-containing sequences. Biochemistry 29, 6521-6534.
5. Beerman, T. A., Woynarowski, J. M., Sigmund, R. D., Gawron, L. S., Rao, K. E. and Lown, J. W. (1991). Netropsin and bisnetropsin analogs as inhibitors of the catalytic activity of mammalian DNA topoisomerase II land topoisomrase cleavable complexes. Biochim. Biophys. Acta 1900, 52-60.
6. Beerman, T. A., McHugh, M. M., Sigmund, R., Lown, J. W., Rao, K. E. and Bathini, Y. (1992). Effects of analogs of the DNA minor groove binder Hoeschst 33258 on topoisomerase II and I mediated activities. Biochim. Biophys. Acta 1131, 53-61.
7. Bell, A., Kittler, L, Löber, G. and Zimmer, C. (1996). Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides. Invest New Drugs 13, 271-284.
8. Berger, J. M., Gamblin, S. J., Harrison, S. C. and Wang, J. C. (1996). Structure and mechanism of DNA topoisomerase II. Nature 379, 225-232.
9. Burckhardt, G., Luck, G., Störl, K., Zimmer, C. and Lown, J. W. (1993). Binding to DNA of selected lexitropsins and effects on prokaryotic topoisomerase activity. Biochim. Biophys. Acta 1173, 266-252.
10. Denny, W. A., Atwell, G. J., Baguley, B. C. and Cain, B. F. (1979). Potential antitumor agents. 29. Quantitative structure-activity relationships for the antileukemic bisquaternary ammonium heterocycles. J. Med. Chem. 22, 134-150.
11. Fesen, M. and Pommier, Y. (1989). Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA. J. Biol. Chem. 264, 11354-11359.
12. Galas, D. J. and Schmitz, A. (1978). DNAase footprinting: a simple method for the detection of protein-DNA binding specificity. Nucl. Acids Res. 5, 3157-3170.
13. Gao, X. and Patel, D. J. (1989). Solution structure of the chromomycin-DNA complex. Biochemistry 28, 751-762.
14. Gao, X., Mirau, P. and Patel, D. J. (1992). Structure refinement of the chromomycin dimer-DNA oligomr complex in solution. J. Mol. Biol. 223, 259-279.
15. Gao, Y. G., Sriram, M., Denny, W. A. and Wang, A. H. (1993). Minor groove binding of SN6999 to an alkylated DNA: molecular structure of d(CGC[e6G]AATTCGCG)-SN6999 complex. Biochemistry 32, 9639-9648.
16. Geierstanger, H. and Wemmer, D. E. (1995). Complexes of the minor groove of DNA. Annu. Rev. Biophys. Biomol. Struct. 24, 463-493.
17. Gellert, M. (1981). DNA topoisomerases. Annu. Rev. Biochem. 50, 879-910.
18. Goodsell, D. and Dickerson, R. E. (1986). Isohelical analysis of DNA groove-binding drugs. J. Med. Chem. 29, 727-733.
19. Goodsell, D. S., Ng, H. L., Kopka, M. L., Lown, J. W. and Dickerson, R. E. (1995). Structure of a dicationic monoimidazole lexitropsin bound to DNA. Biochemistry 34, 16654-16661.
20. Guo, D., Gupta, R. and Lown, J. W. (1993). DNA sequence-selective binding of head-to-tail linked bis-lexitropsins: relation of phasing to cytotoxic potency. Anti-Cancer Drug Design 8, 369-397.
21. Hogan, M., Dattagupta, N. and Crothers, D. M. (1979). Transmission of allosteric effects in DNA. Nature 278, 521-524.
22. 2+ coordination. Biochimie 77, 729-738.
23. Kissinger, K. L., Dabrowiak, J. C. and Lown, J. W. (1990). Molecular recognition between oligopeptides and nucleic acids: DNA binding specificity of a series of bis netropsin analogues deduced from footprinting analysis. Chem. Res. Toxicol. 3, 162-168.
24. Kittler, L., Wähnrt, U., Baguley, B. C., Bailly, C., Waring, M. J. and Löber, G. (1996). Sequence-specific binding of antitumour bisquaternary ammonium heterocycles to DNA and inhibition of polymerase activity in vitro. Anti-Cancer Drug Design 11, 101-115.
25. Kittler, L., Matesoi, D., Bell, A., Baguley, B. C., Unger, E. and Löber, G. (1997). Sequence-specific intractions of minor groove binders with the 154 base pair HindIII-RsaI restriction fragment of cDNA of the human tau 40 protein involved in pathology of alzheimer's disease. biochem. Molec. Biol. Internat. 41, 143-152.
26. Kopka, M. L., Yoon, C., Goodsell, D., Pjura, P. and Dickerson, R. E. (1985). The molecular origin of DNA-drug specificity in netropsin and distamycin. Proc. Natl Acad. Sci. USA 82, 1376-1380.
27. Krugh, T. R. (1994). Drug-DNA interactions. Curr. Opin. Struct. Biol. 4, 351-364.
28. Lee, M. P., Sander, M. and Hsieh, T-s. (1989). Nuclease protection by drosophila DNA topoisomerase II. J. Biol. Chem. 264, 21779-21787.
29. 2 and a minor-groove-biding drug. Biochemistry 25, 5902-5910.
30. 3 to DNA. Biochemistry 33, 1419-1424.
31. Lown, J. W. (1994). DNA recognition by lexitropsins, minor groove binding agents. J. Mol. Recogn. 7, 79-88.
32. Luck, G., Reinert, K.-E., Baguley, B. and Zimmer, C. (1987). Interaction of the nonintercalative antitumor drugs SN-6999 and SN-18071 with DNA: influence of ligand structure on the binding specificity. J. Biomol. Struct. Dynam. 4, 1079-1093.
33. Luck, G., Störl, J., Baguley, B. and Zimmer, C. (1992). DNA binding of the nonintercalative ligands SN-6132, SN-6131 and SN-6113: minor variations of the ligand structure may cause changes in the base pair preference. J. Biomol. Struct. Dynam. 10, 551-564.
34. Nunn, C. M., Garman, E. and Neidle, S. (1997). Crystal structure of the DNA decamer d(CGCAATTGCG) complexed with the minor groove binding drug netropsin. Biochemistry 36, 4792-4799.
35. Maxwell, A. (1996). Protein gate in DNA topoisomerase II. Nat. Struct. Biol. 3, 109-112.
36. Pelton, J. G. and Wemmer, D. E. (1989). Structural characterization of a 2:1 distamycinA d(CGCAAATTGGC) complex by two-dimensional NMR. Proc. Natl Acad. Sci. USA 86, 5723-5727.
37. Poncz, M., Schwartz, E., Ballantine, M. and Surrey, S. (1983). Nucleotide sequence analysis of the γβ-globin gene region in humans. J. Biol. Chem. 258, 11599-11609.
38. Pullman, B. (1989). Molecular mechanisms of specificity in DNA-antitumor drug interactions. Adv. Drug Res. 18, 1-113.
39. Reinert, K.-E. (1981). Aspects of specific DNA-protein interacton; local bending of DNA molecules by in-register binding of the oligopeptide antibiotic distamycin. Biophys. Chem. 13, 1-14.
40. Reinert, K.-E. (1993). Aboliton of intrinsically bent DNA structure components in AT cluster by netropsin interaction; titration viscometric investigators. J. Biomol. Struct. Dynam. 10, 973-990.
41. Rentzeperis, D., Marky, L. A., Dwyer, T. J., Geierstanger, B. H., Pelton, J. G. and Wemmer, D. E. (1995). Interaction of minor groove ligands to an AAATT/AATTT site: correlaton of thermodynamic characterization and solution structure. Biochemistry 31, 2937-2945.
42. Roca, J. and Wang, J. C. (1994). DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism. Cell 77, 609-161.
43. Rocca, J. (1995). The mechanisms of DNA topoisomerases. TIBS 20, 156-160.
44. Rydzewski, J. M., Leupin, W. and Chazin, W. (1996). The width of the minor groove affects the binding of the bisquaternary heterocycle SN-6999 to duplex DNA. Nucl. Acids Res. 24, 1287-1293.
45. Sayers, E. W. and Waring, M. J. (1993). Footprinting titration studies on the binding of echinomycin to DNA incapable of forming Hoogsteen base pairs. Biochemistry 32, 9094-9107.
46. 3 as a blueprint for designed metal complexes. J. Am. Chem. Soc. 116, 2641-2642.
47. Sørensen, B. S., Jensen, P. S., Andersen, A. H., Christiansen, K., Alsner, J., Thomsen, B. and Westergaard, O. (1990). Stimulation of topoisomerase II mediated DNA cleavage at specific sequence elements by the 2-nitroimidazole Ro 15-0216. Biochemistry 29, 9507-9515.
48. Spitzner, J. R., Chung, I. K. and Muller, M. T. (1990). Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats. Nucl. Acids Res. 18, 1-11.
49. Strausfeld, U. and Richter, A. (1989). Simultaneous purification of DNA topoisomerasel I and II from eukaryotic cells. Prep. Biochem. 19, 37-48.
50. Thomson, B., Bednixen, C., Lund, K., Andersen, A. H., Sørensen, B. S. and Westergaard, O. (1990). Characterization of the interaction between topoisomerase II and DNA by transcriptional footprinting. J. Mol. Biol. 215, 237-244.
51. Wang, H., Di Gate, R. J. and Seeman, N. C. (1996). An RNA topoisomerase. Proc. Natl Acad. Sci. USA 93, 9477-9482.
52. Wang, J. C. (1985). DNA topoisomerases. Annu. Rev. Biochem. 54, 665-697.
53. Wang, J. C. (1996). DNA topoisomerases. Annu. Rev. Biochem. 65, 635-692.
54. Waring, M. J. (1981). DNA modification and cancer. Ann. Rev. Biochem. 50, 159-192.
55. Woynarowski, J. M., McHugh, M., Signund, R. D. and Beerman, T. A. (1989a). Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, hoechst 33258, and 4′,6-diamidine-2-phenylindole. Mol. Pharmacol. 35, 117-182.
56. Woynarowski, J. M., Sigmund, R. D. and Beerman, T. A. (1989b). DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells. Biochemistry 28, 3850-3855.
57. Zakrzewska, K., Lavery, R. and Pullman, B. (1983). Theoretical studies of the selective binding to DNA of two non-intercalating ligands: netropsin and SN 18071. Nucl. Acids Res. 11, 8825-8839.
58. Zimmer, C. (1975). Effects of the antibiotics netropsin and distamycin A on the structure and function of nucleic acids. Prog. Nucleic Acid Res. Mol. Miol. 15, 285-318.
59. Zimmer, C. and Wähnert, U. (1986). Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. Prog. Biophys. molec. Biol. 47, 31-112.